INFLUENZA, HUMAN
Clinical trials for INFLUENZA, HUMAN explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA, HUMAN trials appear
Sign up with your email to follow new studies for INFLUENZA, HUMAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests new flu shot formula for seniors
⭐️ VACCINE ⭐️ OngoingThis study aims to find out if two new versions of the flu shot, which contain an extra ingredient called an adjuvant, work better than the standard flu shot at preventing the flu in adults aged 65 and older. It will enroll 35,800 participants to compare how often people get the …
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE3 • Sponsor: Seqirus • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 01, 2026 14:42 UTC
-
Next-Gen flu shot: can mRNA tech beat the seasonal bug?
⭐️ VACCINE ⭐️ OngoingThis study is testing new flu vaccines made with mRNA technology, similar to some COVID-19 shots. It aims to see how well they trigger an immune response and how safe they are in healthy adults aged 18 and older. The trial is comparing different versions of the vaccine to gather …
Matched conditions: INFLUENZA, HUMAN
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 17, 2026 12:55 UTC
-
Can a simple letter stop the flu and prevent strokes?
Prevention OngoingThis study is testing whether sending reminder letters from a local pharmacist can encourage more adults in Alberta, Canada, to get their flu shot or travel vaccines. Researchers will mail one of two different informational letters to 20,000 pharmacy customers to see which messag…
Matched conditions: INFLUENZA, HUMAN
Phase: NA • Sponsor: University of Calgary • Aim: Prevention
Last updated Mar 18, 2026 14:41 UTC
-
Scientists probe nose vs. arm: which flu vaccine builds better defenses?
Knowledge-focused OngoingThis study aims to understand how the body's immune system responds differently to two types of flu vaccines: a nasal spray and a traditional shot. Researchers will compare immune responses in the nose, lungs, and blood of 60 healthy adults to identify markers that could help des…
Matched conditions: INFLUENZA, HUMAN
Phase: EARLY_PHASE1 • Sponsor: Copenhagen Respiratory Research • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC